ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SMMT Summit Therapeutics Inc

3.5001
-0.0899 (-2.50%)
Apr 25 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Summit Therapeutics Inc SMMT NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.0899 -2.50% 3.5001 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.53 3.44 3.62 3.55 3.59
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/24/202416:30BWSummit Therapeutics to Host First Quarter 2024 Financial..
4/11/202416:30BWSummit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned..
4/10/202407:00BWSummit Therapeutics to Present at the Stifel 2024 Targeted..
3/22/202407:00BWPromising Intracranial Anti-Tumor Activity and Safety Data..
3/14/202407:00BWIntracranial Anti-Tumor Activity and Safety of Ivonescimab..
3/05/202416:05EDGAR2Form 8-K - Current report
3/05/202407:00BWSummit Therapeutics to Present at the Barclays 26th Annual..
2/20/202408:05EDGAR2Form 8-K - Current report
2/20/202407:55EDGAR2Form S-3 - Registration statement under Securities Act of..
2/20/202407:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/20/202407:00BWSummit Therapeutics Reports Financial Results and..
2/15/202417:25EDGAR2Form 8-K - Current report
2/14/202416:35EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
2/14/202410:29BWSummit Therapeutics to Host Fourth Quarter & Full Year 2023..
2/14/202407:00BWSummit Therapeutics to Host Fourth Quarter & Full Year 2023
2/07/202407:00BWSummit Therapeutics to Present at Oppenheimer’s 34th Annual..
1/08/202409:07EDGAR2Form 8-K - Current report
1/08/202409:00BWSummit Therapeutics Announces Updated Phase II Data for..
1/04/202416:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202416:06EDGAR2Form 8-K - Current report
1/03/202407:30BWSummit Therapeutics to Present at the 42nd Annual J.P...
12/13/202316:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/07/202308:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202308:03EDGAR2Form 8-K - Current report
11/07/202307:00BWSummit Therapeutics Reports Financial Results and..
11/02/202316:41BWLaura Chow, MD, Cancer Immunotherapy Trailblazer, Joins..
10/31/202316:02EDGAR2Form 8-K - Current report
10/31/202308:00BWIvonescimab’s Novel Mechanism of Action Highlighting..
10/26/202308:00BWSummit Therapeutics to Host Q3 2023 Financial Results &..
10/19/202308:00BWH. Jack West, MD, Renowned Oncologist & Lung Cancer Expert,..
10/16/202307:46EDGAR2Form 8-K - Current report
10/16/202307:00BWSummit Therapeutics Appoints Proven Biotech Leader Manmeet..
9/19/202315:40EDGAR2Form DEF 14A - Other definitive proxy statements
9/08/202316:08EDGAR2Form PRE 14A - Other preliminary proxy statements
8/09/202316:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/202308:03EDGAR2Form 8-K - Current report
8/09/202307:00BWSummit Therapeutics Reports Financial Results and..
8/02/202316:05EDGAR2Form 8-K - Current report
8/02/202308:00BWSummit Therapeutics to Host Q2 2023 Financial Results &..
6/04/202308:00BWPromising Data for Investigational Innovative Bispecific..
6/01/202307:30BWIvonescimab Updated Data to be Featured at ASCO 2023
5/11/202307:30BWSummit Therapeutics Reports Financial Results and..
5/09/202307:30BWSummit Therapeutics Announces First Patient Treated in Phase..
5/03/202308:30BWSummit Therapeutics Announces Initial Indications for..

Your Recent History

Delayed Upgrade Clock